R&D
더 나은 미래를 위해 SCM생명과학은 최선을 다할 것입니다.
성과
기간별 검색
  • Hypoxia induces glucose uptake and metabolism of adipose‑derived stem cells.
    Park HS, Kim JH, Sun BK, Song SU, Suh W, Sung JH.

    Mol Med Rep. 2016 Nov14(5):4706-4714. doi: 10.3892/mmr.2016.5796.
  • Neuroprotective effect of mesenchymal stem cell through complement component 3 downregulation after transient focal cerebral ischemia in mice.
    Jung HS, Jeong SY, Yang J, Kim SD, Zhang B, Yoo HS, Song SU, Jeon MS, Song YS.

    Neurosci Lett. 2016 Oct 28633:227-234. doi: 10.1016/j.neulet.2016.09.032. Epub 2016 Sep 20.
  • Hypoxia Suppresses Spontaneous Mineralization and Osteogenic Differentiation of Mesenchymal Stem Cells via IGFBP3 Up-Regulation.
    Kim JH, Yoon SM, Song SU, Park SG, Kim WS, Park IG, Lee J, Sung JH.

    Int J Mol Sci. 2016 Aug 2417(9). pii: E1389. doi: 10.3390/ijms17091389.
  • Intracavernous delivery of clonal mesenchymal stem cells rescues erectile function in the streptozotocin-induced diabetic mouse.
    Ryu JK, Kim DH, Song KM, Ryu DS, Kim SN, Shin DH, Yi T, Suh JK, Song SU.

    Andrology. 2016 Jan;4(1):172-84. doi: 10.1111/andr.12138. Epub 2015 Dec 29.

    당뇨동물모델에서 고순도 성체줄기세포가 발기부전을 개선 할 수 있음을 제시한 논문
  • Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study.
    Yi HG, Yahng SA, Kim I, Lee JH, Min CK, Kim JH, Kim CS, Song SU.

    Korean J Physiol Pharmacol. 2016 Jan;20(1):63-7. doi: 10.4196/kjpp.2016.20.1.63. Epub 2015 Dec 31.

    난치성 이식편대숙주질환을 위한 일반적 치료의 동종 고순도성체줄기세포 치료제 : 임상 1상 시험
1